PRIDE III Prison Interventions and HIV Prevention Collaboration
Launched by YALE UNIVERSITY · Apr 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The PRIDE III trial is exploring how to improve access to a treatment called Opioid Agonist Therapy (OAT) for people who use opioids and are involved with the justice system, such as prisons and probation in four countries: Tajikistan, Kyrgyzstan, Moldova, and Georgia. The researchers want to understand what obstacles exist that make it difficult to offer this treatment and how to create a supportive learning environment for those providing OAT. They will also analyze the effectiveness of these efforts in helping individuals who inject drugs.
To participate in this study, individuals must be at least 18 years old and currently involved in probation, either as a provider or as someone receiving support. They will gather information through surveys and focus groups, which will help them identify specific needs and challenges. This study is not yet recruiting participants, but it aims to make a significant impact on improving health care for people dealing with opioid use and HIV in these communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Aim 1:
- • 1. Quantitative surveys for prison OAT providers
- • Being 18 years or older
- • Being currently assigned and working as a probation OAT provider for a probation site
- • 2. ECHO procedures
- Aim 2:
- • 1. Quantitative surveys for people in probation
- • Being 18 years or older
- • Screen yes to opioid injection on the online screener questionnaire
- • Currently in probation
- • 2. Quantitative surveys for probation and prison officers
- • Being 18 years or older
- • Being currently assigned and working as a probation or prison officer at a probation site
- • 3. Focus Groups (People in probation)
- • Being 18 years or older
- • Screen yes to opioid injection criteria on the online screener
- • Currently in probation
- • 4. Focus Groups (Probation and prison officers)
- • Being 18 years or older
- • Being currently assigned and working as a probation or prison officer at a probation
- • Has more than 3 months of field experience
- • Works at a probation site within 25 kilometers of an OAT site
- Exclusion Criteria:
- • -
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Tbilisi, , Georgia
Bishkek, , Kyrgyzstan
Chisinau, , Moldova, Republic Of
Dushanbe, , Tajikistan
Patients applied
Trial Officials
Frederick L Altice, MD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported